What is it about?
This paper describes two epidemiologically-linked human cases of Lassa Fever treated with a combination of ribavirin and favipiravir.
Featured Image
Why is it important?
The cases in this article represent the first use of favipiravir to treat Lassa Fever in humans.
Read the Original
This page is a summary of: Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever, Clinical Infectious Diseases, June 2017, Oxford University Press (OUP),
DOI: 10.1093/cid/cix406.
You can read the full text:
Contributors
The following have contributed to this page
